Vinay Prasad & Moderna

Vinay Prasad: Dr. Vinay Prasad, a former top United States — Food and Drug Administration official, initially blocked Moderna's application, raising concerns about the comparator vaccine used in trials. His actions highlighted heightened scrutiny but were ultimately challenged and overturned.

Moderna: Moderna is the developer of the mFlusiva mRNA flu vaccine, which is currently under review for approval by the United States — Food and Drug Administration. The positive recommendation from the advisory panel is a significant step towards market entry, potentially boosting its stock and market position in the vaccine sector.

Vinay Prasad: As a top deputy at the United States — Food and Drug Administration, Vinay Prasad co-authored the New England Journal of Medicine piece announcing the change in drug approval requirements. However, he has also taken a more restrictive approach to vaccines and gene therapies, creating some inconsistency.

Vinay Prasad: Dr. Vinay Prasad, the United States — Food and Drug Administration vaccine director, issued the refusal-to-file letter to Moderna, citing issues with its clinical trial methodology.

Vinay Prasad: Dr. Vinay Prasad, director of the United States — Food and Drug Administration's Center for Biologics Evaluation and Research, initially overruled agency reviewers and signed the refusal letter for Moderna's vaccine application, citing concerns about the trial's control arm.

Vinay Prasad: Vinay Prasad>>>, a close ally of Marty Makary>>>, served as the FDA's vaccine and biotech chief but was pushed out twice, contributing to the agency's internal dysfunction and leadership instability.

Vinay Prasad: Vinay Prasad, the United States — Food and Drug Administration's vaccine chief who advocated for placebo-controlled trials, is leaving the agency, which might influence future regulatory approaches.